KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Co-Diagnostics (CODX) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Co-Diagnostics' Change in Acquisitions & Divestments fell 8762.11% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.5 million, marking a year-over-year decrease of 4208.19%. This contributed to the annual value of $58.8 million for FY2024, which is 5381.95% down from last year.
  • Latest data reveals that Co-Diagnostics reported Change in Acquisitions & Divestments of $2.3 million as of Q3 2025, which was down 8762.11% from $17.6 million recorded in Q2 2025.
  • Co-Diagnostics' 5-year Change in Acquisitions & Divestments high stood at $38.9 million for Q2 2023, and its period low was -$3981.0 during Q4 2021.
  • In the last 5 years, Co-Diagnostics' Change in Acquisitions & Divestments had a median value of $11.6 million in 2024 and averaged $13.0 million.
  • In the last 5 years, Co-Diagnostics' Change in Acquisitions & Divestments plummeted by 10023.22% in 2021 and then soared by 12648849.54% in 2022.
  • Co-Diagnostics' Change in Acquisitions & Divestments (Quarter) stood at -$3981.0 in 2021, then skyrocketed by 126488.5% to $5.0 million in 2022, then surged by 634.81% to $37.0 million in 2023, then crashed by 62.85% to $13.7 million in 2024, then tumbled by 83.6% to $2.3 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $2.3 million for Q3 2025, versus $17.6 million for Q2 2025 and $13.9 million for Q1 2025.